Sven A. Lang

2.0k total citations
44 papers, 1.5k citations indexed

About

Sven A. Lang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Sven A. Lang has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 13 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Sven A. Lang's work include Cancer, Hypoxia, and Metabolism (12 papers), Heat shock proteins research (11 papers) and Angiogenesis and VEGF in Cancer (8 papers). Sven A. Lang is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), Heat shock proteins research (11 papers) and Angiogenesis and VEGF in Cancer (8 papers). Sven A. Lang collaborates with scholars based in Germany, United States and China. Sven A. Lang's co-authors include Edward K. Geissler, Hans J. Schlitt, Oliver Stoeltzing, Christian Moser, Andreas Gäumann, Claus Hellerbrand, Gabriel Glockzin, Dagmar Klein, Akira Mori and Christina Hackl and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and PLoS ONE.

In The Last Decade

Sven A. Lang

43 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sven A. Lang Germany	24	928	449	298	218	174	44	1.5k
Franziska van Zijl Austria	11	824 0.9×	604 1.3×	371 1.2×	193 0.9×	164 0.9×	13	1.6k
Limei Liu China	22	1.1k 1.2×	565 1.3×	507 1.7×	182 0.8×	125 0.7×	42	1.7k
Alessio Giubellino United States	21	605 0.7×	329 0.7×	308 1.0×	128 0.6×	164 0.9×	77	1.3k
Sheng-Chieh Hsu Taiwan	16	1.0k 1.1×	811 1.8×	364 1.2×	151 0.7×	286 1.6×	16	1.7k
Yongfu Zhao China	24	923 1.0×	261 0.6×	529 1.8×	301 1.4×	158 0.9×	60	1.5k
Dae‐Kee Kim South Korea	27	982 1.1×	640 1.4×	212 0.7×	160 0.7×	112 0.6×	68	1.8k
Hudie Wei China	14	835 0.9×	550 1.2×	220 0.7×	211 1.0×	142 0.8×	31	1.5k
Chia‐Lang Hsu Taiwan	25	1.1k 1.2×	364 0.8×	480 1.6×	387 1.8×	312 1.8×	118	1.8k
Ying Hu China	26	1.1k 1.2×	510 1.1×	462 1.6×	258 1.2×	274 1.6×	74	1.8k

Countries citing papers authored by Sven A. Lang

Since Specialization

Citations

This map shows the geographic impact of Sven A. Lang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sven A. Lang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sven A. Lang more than expected).

Fields of papers citing papers by Sven A. Lang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sven A. Lang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sven A. Lang. The network helps show where Sven A. Lang may publish in the future.

Co-authorship network of co-authors of Sven A. Lang

This figure shows the co-authorship network connecting the top 25 collaborators of Sven A. Lang. A scholar is included among the top collaborators of Sven A. Lang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sven A. Lang. Sven A. Lang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yong, Jingjiao, et al.. (2025). Characterization of cis-polyisoprene produced in Periploca sepium, a novel promising alternative source of natural rubber. Communications Biology. 8(1). 372–372. 3 indexed citations

Lang, Sven A., Jun Yang, Yong Zhang, et al.. (2025). Application of Wearable Insole Sensors in In-Place Running: Estimating Lower Limb Load Using Machine Learning. Biosensors. 15(2). 83–83. 2 indexed citations

Zhang, Yunhong, Juan Hu, Ge Tian, et al.. (2025). Dihydroflavonol 4-reductase from Iris lactea has distinct substrate specificity and promoting the synthesis of delphinidin-based anthocyanins. Plant Physiology and Biochemistry. 223. 109805–109805.

Seitz, Tatjana, Peter Dietrich, Wolfgang E. Thasler, et al.. (2022). Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche. International Journal of Molecular Sciences. 23(19). 11524–11524. 7 indexed citations

Dollinger, Marco, Florian Zeman, Christoph Nießen, et al.. (2015). Bile Duct Injury after Irreversible Electroporation of Hepatic Malignancies: Evaluation of MR Imaging Findings and Laboratory Values. Journal of Vascular and Interventional Radiology. 27(1). 96–103. 35 indexed citations

Hellerbrand, Claus, Christian Moser, Katharina Schmidt, et al.. (2015). mTOR inhibition improves fibroblast growth factor receptor targeting in hepatocellular carcinoma. British Journal of Cancer. 112(5). 841–850. 33 indexed citations

Fendrich, Volker, Dominik Wiese, Jens Waldmann, et al.. (2014). Inhibition of Heat Shock Protein 90 with AUY922 Represses Tumor Growth in a Transgenic Mouse Model of Islet Cell Neoplasms. Neuroendocrinology. 100(4). 300–309. 7 indexed citations

Gäumann, Andreas, Hannes C. A. Drexler, Sven A. Lang, et al.. (2014). The inhibition of tyrosine kinase receptor signalling in leiomyosarcoma cells using the small molecule kinase inhibitor PTK787/ZK222584 (Vatalanib®). International Journal of Oncology. 45(6). 2267–2277. 11 indexed citations

Gottfried, Eva, Sven A. Lang, Kathrin Renner, et al.. (2013). New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells. PLoS ONE. 8(7). e66987–e66987. 90 indexed citations

10.

Lang, Sven A., Christina Hackl, Christian Moser, et al.. (2010). Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1803(4). 435–442. 42 indexed citations

11.

Hackl, Christina, Sven A. Lang, Christian Moser, et al.. (2010). Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition. BMC Cancer. 10(1). 668–668. 65 indexed citations

12.

Mori, Akira, Christian Moser, Sven A. Lang, et al.. (2009). Up-Regulation of Krüppel-Like Factor 5 in Pancreatic Cancer Is Promoted by Interleukin-1β Signaling and Hypoxia-Inducible Factor-1α. Molecular Cancer Research. 7(8). 1390–1398. 61 indexed citations

13.

Hackl, Christina, Akira Mori, Christian Moser, et al.. (2009). Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental models. Surgery. 147(5). 704–712. 13 indexed citations

14.

Lang, Sven A., Christian Moser, Claus Hellerbrand, et al.. (2008). Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice #. Hepatology. 49(2). 523–532. 49 indexed citations

15.

Lang, Sven A., Andreas Gäumann, Akira Mori, et al.. (2008). Inhibition of insulin-like growth factor-I receptor (IGF-IR) using NVP-AEW541, a small molecule kinase inhibitor, reduces orthotopic pancreatic cancer growth and angiogenesis. European Journal of Cancer. 44(11). 1577–1586. 62 indexed citations

16.

Moser, Christian, Sven A. Lang, Karen Lundgren, et al.. (2008). Targeting Hsp90 using EC154, a novel synthetic Hsp90 inhibitor, impairs multiple oncogenic signaling pathways in human gastric and pancreatic cancer cells and reduces tumor growth in vivo. Cancer Research. 68. 1181–1181. 1 indexed citations

17.

Lang, Sven A., Dagmar Klein, Christian Moser, et al.. (2007). Inhibition of heat shock protein 90 impairs epidermal growth factor–mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Molecular Cancer Therapeutics. 6(3). 1123–1132. 95 indexed citations

18.

Lang, Sven A., Andreas Gäumann, Gudrun E. Koehl, et al.. (2007). Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. International Journal of Cancer. 120(8). 1803–1810. 138 indexed citations

19.

Moser, Christian, Sven A. Lang, & Oliver Stoeltzing. (2007). The Direct Effects of Anti–Vascular Endothelial Growth Factor Therapy on Tumor Cells. Clinical Colorectal Cancer. 6(8). 564–571. 8 indexed citations

20.

Bitha, Panayota, et al.. (1989). A new family of water-soluble, third-generation antitumor platinum complexes. Journal of Medicinal Chemistry. 32(9). 2063–2067. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact